Mechanisms of stabilization of the insulin hexamer through allosteric ligand interactions

被引:76
作者
RahuelClermont, S
French, CA
Kaarsholm, NC
Dunn, MF
机构
[1] UNIV CALIF RIVERSIDE,DEPT BIOCHEM 015,RIVERSIDE,CA 92521
[2] NOVO NORDISK AS,NOVO RES INST,DK-2880 BAGSVAERD,DENMARK
关键词
D O I
10.1021/bi963038q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The insulin hexamer is an allosteric protein capable of undergoing transitions between three conformational states: T-6, T3R3, and R-6. These transitions are mediated by the binding of phenolic compounds to the R-state subunits, which provide positive homotropic effects, and by the coordination of anions to the bound metal ions, which act as heterotropic effecters. Since the insulin monomer is far more susceptible than the hexamer to thermal, mechanical, and chemical degradation, insulin-dependent diabetic patients rely on pharmaceutical preparations of the Zn-insulin hexamer, which act as stable forms of the biologically active monomeric insulin. In this study, the chromophoric chelator 2,2',2 ''-terpyridine (terpy) has been used as a kinetic probe of insulin hexamer stability to measure the effect of homotropic and heterotropic effecters on the dissociation kinetics of the Zn2+- and Co2+-insulin hexamer complexes. We show that the reaction between terpy and the R-state-bound metal ion is limited by the T3R3 reversible arrow T-6 Or R-6 reversible arrow T3R3 conformational transition steps and the dissociation of one anionic ligand, or one anionic ligand and three phenolic ligand molecules, respectively, for T3R3 and R-6. Consequently, because the activation energies of these steps are dominated by the ground-state stabilization energy of the R-state species, the kinetic stabilization of the insulin hexamer toward terpy-induced dissociation is linked to the thermodynamic stabilization of the hexamer. The mass action effect of anion binding and, foremost, of phenolic ligand binding provides the major mechanism of stabilization, resulting in the tightening of the tertiary and quaternary hexamer structures. Using this kinetic method, we show that the R-6 conformation of Zn-insulin in the presence of Cl- ion and resorcinol is > 1.5 million-fold more stable than the T-3 units Of T-6 and T3R3 and >70 000-fold more stable than the R-3 unit of T3R3. Furthermore, the stabilization effect is correlated with the affinity of the ligands: the tighter the binding, the slower the reaction between terpy and R-state-bound metal ion. These concepts provide a new basis for the pharmaceutical improvement of the physicochemical stability of formulations both for native insulin and for fast-acting monomeric insulin analogues through ligand-mediated allosteric interactions.
引用
收藏
页码:5837 / 5845
页数:9
相关论文
共 42 条
[1]   THE STRUCTURE OF 2ZN PIG INSULIN CRYSTALS AT 1.5-A RESOLUTION [J].
BAKER, EN ;
BLUNDELL, TL ;
CUTFIELD, JF ;
CUTFIELD, SM ;
DODSON, EJ ;
DODSON, GG ;
HODGKIN, DMC ;
HUBBARD, RE ;
ISAACS, NW ;
REYNOLDS, CD ;
SAKABE, K ;
SAKABE, N ;
VIJAYAN, NM .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1988, 319 (1195) :369-&
[2]  
Banting FG, 1922, J LAB CLIN MED, V7, P464
[3]   STRUCTURE OF INSULIN IN 4-ZINC INSULIN [J].
BENTLEY, G ;
DODSON, E ;
DODSON, G ;
HODGKIN, D ;
MERCOLA, D .
NATURE, 1976, 261 (5556) :166-168
[4]   Hierarchical modeling of phenolic ligand binding to 2Zn-insulin hexamers [J].
Birnbaum, DT ;
Dodd, SW ;
Saxberg, BEH ;
Varshavsky, AD ;
Beals, JM .
BIOCHEMISTRY, 1996, 35 (17) :5366-5378
[5]   LIGAND-BINDING TO WILD-TYPE AND E-B13Q MUTANT INSULINS - A 3-STATE ALLOSTERIC MODEL SYSTEM SHOWING HALF-SITE REACTIVITY [J].
BLOOM, CR ;
CHOI, WE ;
BRZOVIC, PS ;
HA, JJ ;
HUANG, ST ;
KAARSHOLM, NC ;
DUNN, MF .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 245 (04) :324-330
[6]  
Blundell T, 1972, ADV PROTEIN CHEM, V1972, P279, DOI 10.1016/S0065-3233(08)60143-6
[7]   CHARACTERIZATION OF THE R-STATE INSULIN HEXAMER AND ITS DERIVATIVES - THE HEXAMER IS STABILIZED BY HETEROTROPIC LIGAND-BINDING INTERACTIONS [J].
BRADER, ML ;
KAARSHOLM, NC ;
LEE, RWK ;
DUNN, MF .
BIOCHEMISTRY, 1991, 30 (27) :6636-6645
[8]   MONOMERIC INSULINS AND THEIR EXPERIMENTAL AND CLINICAL IMPLICATIONS [J].
BRANGE, J ;
OWENS, DR ;
KANG, S ;
VOLUND, A .
DIABETES CARE, 1990, 13 (09) :923-954
[9]  
Brange J, 1993, Pharm Biotechnol, V5, P315
[10]  
Brange J., 1987, Galenics of Insulin, The Physico-chemical and Pharmaceutical Aspects of Insulin and Insulin Preparations, P1